Binay Shah, Co-Founder, President and CEO at Binaytara, shared a post on LinkedIn:
“CALL FOR ABSTRACTS: Binaytara 2026 National Summit on Hematologic Cancers!
Abstract portal.
Why submit?
- Grant Opportunity: Authors of accepted abstracts will be eligible to submit research proposals for grant funding of up to $50,000 each! (Multiple grants will be awarded).
- Visibility: Share your findings with leading experts, clinicians, and researchers in the field.
- Impact: Contribute to the evolving landscape of blood cancer treatment and patient care.”
Other articles about Hematologic Cancer on OncoDaily.